Saving for university with investment companies
David Prosser discusses why closed-ended funds are worth considering.
The case for investing in biotech
Carl Harald Janson, Manager, International Biotechnology Trust.
My best investment - Dan Mahony
Daniel Mahony, Fund Manager, Polar Capital Global Healthcare Growth & Income.
Discounts: challenge or opportunity?
David Prosser explains investment company discounts and premiums.
The advantages of saving for children in a closed-ended fund
David Prosser looks at the long-term returns offered by investment companies.
Sell in May and go away?
David Prosser explains why investors should instead take a long-term view.
The outlook for UK markets
Guy Anderson discusses his investment approach in addressing the unprecedented reduction in oil prices.
In pursuit of absolute value
The outlook for the UK as the election adds “an element of uncertainty among investors”.
The advantages of investment company regular savings
David Prosser explains why you shouldn’t leave ISA planning to the last minute.
Ian Sayers blog: VCT investment: spot the connection
Ian Sayers takes a look at some of the companies backed by VCTs.
